Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-24-084955

Options or other derivatives

  • SVP, CFO acquired 8,550 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Taylor Daphne SVP, CFO 2024-07-17 Grant or award · Restricted Stock Unit +8,550 8,550 D
Loading xslF345X05/ownership.xml…